Beijing Biostar Pharmaceuticals Co., Ltd. (HKG:2563)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
4.500
0.00 (0.00%)
May 7, 2026, 3:43 PM HKT

HKG:2563 Ratios and Metrics

Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
1,6411,7837,182---
Market Cap Growth
-72.73%-75.18%----
Enterprise Value
1,1351,2116,639---
Last Close Price
4.504.8919.70---
PS Ratio
44.1948.0293.92---
PB Ratio
2.212.408.54---
P/TBV Ratio
2.262.458.54---
EV/Sales Ratio
30.5632.6186.81---
Debt / Equity Ratio
0.000.000.000.000.000.00
Net Debt / Equity Ratio
-0.68-0.68-0.71-0.79-0.84-0.85
Net Debt / EBITDA Ratio
3.503.503.522.773.932.81
Net Debt / FCF Ratio
--3.923.226.548.95
Asset Turnover
0.040.040.090.080.040.07
Inventory Turnover
0.070.070.370.680.330.29
Quick Ratio
7.537.537.4913.5314.8545.76
Current Ratio
8.338.338.8314.4815.5647.70
Return on Equity (ROE)
-18.04%-18.04%-18.99%-23.84%-17.72%-28.90%
Return on Assets (ROA)
-10.22%-10.22%-12.47%-15.93%-12.84%-18.74%
Return on Capital Employed (ROCE)
-19.60%-19.60%-20.20%-29.70%-22.20%-31.10%
Earnings Yield
-8.91%-8.20%-2.13%---
FCF Yield
---2.13%---
Buyback Yield / Dilution
-4.31%-3.58%-0.71%---
Source: S&P Global Market Intelligence. Standard template. Financial Sources.